These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 39253075)

  • 1. Application and prospect of organoid technology in breast cancer.
    Huang S; Mei Z; Wan A; Zhao M; Qi X
    Front Immunol; 2024; 15():1413858. PubMed ID: 39253075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of patient-derived organoids for guiding personalized therapies in breast cancer patients.
    Wu H; Wang W; Zhang Y; Chen Y; Shan C; Li J; Jia Y; Li C; Du C; Cai Y; Zhang Y; Zhang S; Wu F
    Int J Cancer; 2024 Jul; 155(2):324-338. PubMed ID: 38533706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exploration of organoid in breast cancer related research].
    Zheng X; Li J; Sheng J; Zhuo Q; Du Q; Xu Y
    Sheng Wu Gong Cheng Xue Bao; 2021 Feb; 37(2):395-403. PubMed ID: 33645143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
    Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G
    Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
    Li J; Liu J; Xia W; Yang H; Sha W; Chen H
    Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organoid technology and applications in cancer research.
    Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
    J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
    Sachs N; de Ligt J; Kopper O; Gogola E; Bounova G; Weeber F; Balgobind AV; Wind K; Gracanin A; Begthel H; Korving J; van Boxtel R; Duarte AA; Lelieveld D; van Hoeck A; Ernst RF; Blokzijl F; Nijman IJ; Hoogstraat M; van de Ven M; Egan DA; Zinzalla V; Moll J; Boj SF; Voest EE; Wessels L; van Diest PJ; Rottenberg S; Vries RGJ; Cuppen E; Clevers H
    Cell; 2018 Jan; 172(1-2):373-386.e10. PubMed ID: 29224780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and Applications of Cancer Organoids in Drug Screening and Personalized Medicine.
    Yang Y; Kong Y; Cui J; Hou Y; Gu Z; Ma C
    Stem Cell Rev Rep; 2024 Jul; 20(5):1213-1226. PubMed ID: 38532032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the application of organoids to breast cancer research.
    Yang L; Liu B; Chen H; Gao R; Huang K; Guo Q; Li F; Chen W; He J
    J Cell Mol Med; 2020 May; 24(10):5420-5427. PubMed ID: 32283573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.
    Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Zhao Z
    In Vitro Cell Dev Biol Anim; 2021 May; 57(5):510-518. PubMed ID: 33950403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy.
    Gong M; Meng H; Tan D; Li P; Qin J; An Q; Shi C; An J
    Animal Model Exp Med; 2023 Oct; 6(5):409-418. PubMed ID: 37890865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
    Ren X; Chen W; Yang Q; Li X; Xu L
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application and Research Progress of Lung Cancer Organoid in Precision Medicine 
for Lung Cancer].
    Huang Z; Li B; Wang Y; Xue J; Wei Z; Liang N; Li S
    Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):276-282. PubMed ID: 38769830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of breast cancer PDO and mini-PDX platform for drug screening and individualized treatment.
    Cui Y; Ran R; Da Y; Zhang H; Jiang M; Qi X; Zhang W; Niu L; Zhou Y; Zhou C; Tang X; Wang K; Yan Y; Ren Y; Dong D; Zhou Y; Wang H; Gong J; Hu F; Zhao S; Zhang H; Zhang C; Yang J
    J Cell Mol Med; 2024 May; 28(9):e18374. PubMed ID: 38722288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and perspective of organoid technology in cancer-related translational medicine.
    Lin Y; Jiang L; He Q; Yuan M; Cao J
    Biomed Pharmacother; 2022 May; 149():112869. PubMed ID: 35358798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoids: An intermediate modeling platform in precision oncology.
    Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
    Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organoid technology in cancer precision medicine.
    Xia X; Li F; He J; Aji R; Gao D
    Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging organoid models: leaping forward in cancer research.
    Fan H; Demirci U; Chen P
    J Hematol Oncol; 2019 Dec; 12(1):142. PubMed ID: 31884964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
    Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer organoids derived from patients: A platform for tailored drug screening.
    Tzeng YT; Hsiao JH; Tseng LM; Hou MF; Li CJ
    Biochem Pharmacol; 2023 Nov; 217():115803. PubMed ID: 37709150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.